(E)-6,10-Dimethylundeca-5,9-dien-2-yl acetate

Catalog No. :
ACRHWA012
CAS No. :
3239-35-8
Molecular Formula :
C15H26O2
Molecular Weight :
238.37

IUPAC Name:(E)-6,10-dimethylundeca-5,9-dien-2-yl acetate

(E)-6,10-Dimethylundeca-5,9-dien-2-yl acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-6,10-Dimethylundeca-5,9-dien-2-yl acetate
IUPAC Name(E)-6,10-dimethylundeca-5,9-dien-2-yl acetate
MDL No.MFCD00555274
Molecular FormulaC15H26O2
Molecular Weight238.37
SMILESCC(OC(C)=O)CC/C=C(C)/CCC=C(C)C
InChI KeyBXGLLMNDXKACMT-JLHYYAGUSA-N
Synonym(E)-6,10-dimethylundeca-5,9-dien-2-yl acetate;5,9-Undecadien-2-ol, 6,10-dimethyl-, acetate, (5E)-;(E)-5-Tangerinol;(E)-6,10-Dimethylundeca-5,9-dien-2-ylacetat;10-Dimethyl-5,9-undecadien-2-ol, acetate, (E)-6;9-Undecadien-2-ol, 6,10-dimethyl-, acetate, (E)-5;trans-5-Tangerinol;Acetic acid (E)-6,10-dimethyl-5,9-undecadien-2-yl ester
CAS No.3239-35-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRHWA012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRHWA012 route product structure diagram
    ACRHWA0123239-35-8
Inquiry

2. ACRHWA012 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRHWA012 route product structure diagram
    ACRHWA0123239-35-8
Inquiry

Comments (0)